EUVIMEDEUVIMED entdecken
Klinische Studie (Phase I)Open Access · CC BY-NC 4.0

Clinical Evaluation of the Effect of Encorafenib on Bupropion, Rosuvastatin, and Coproporphyrin I and Considerations for Statin Coadministration

Joseph Piscitelli iD, Micaela B Reddy, Lance Wollenberg, Laurence Del Frari, Jason Gong, Linda Wood, Yizhong Zhang, Kyle Matschke, Jason H Williams

Clinical Pharmacokinetics · 2024-04 · 63 (4) · 483-496

DOI: 10.1007/s40262-024-01352-9 ↗

Kurz gefasst

Klinische Studie (Phase I) in der Zeitschrift Clinical Pharmacokinetics, online erschienen am 29.02.2024. Verfasst von Joseph Piscitelli und 8 weiteren Autor:innen. Beteiligte Einrichtung: Pfizer Inc, San Diego, CA, USA. Hauptthemen laut MEDLINE: Bupropion, Carbamates, Coproporphyrins, Drug Interactions. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Pfizer.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BupropionCarbamatesCoproporphyrinsDrug InteractionsHydroxymethylglutaryl-CoA Reductase InhibitorsRosuvastatin CalciumSulfonamidesAdultAgedFemaleHumansMaleMiddle AgedATP Binding Cassette Transporter, Subfamily G, Member 2Liver-Specific Organic Anion Transporter 1Aged, 80 and over

Substanzen

ATP Binding Cassette Transporter, Subfamily G, Member 2BupropionCarbamatescoproporphyrin ICoproporphyrinsencorafenibHydroxymethylglutaryl-CoA Reductase InhibitorsLiver-Specific Organic Anion Transporter 1Rosuvastatin CalciumSLCO1B1 protein, human

Autor:innen und Institutionen

  • Pfizer Inc, San Diego, CA, USA.
  • Pfizer Inc, Boulder, CO, USA.
  • Pierre Fabre Medicament, Toulouse, France.
  • Pfizer Inc, New York, NY, USA.
  • Pfizer Inc, Groton, CT, USA.
  • Pfizer Inc, Collegeville, PA, USA.

ORCID-Profile: Joseph Piscitelli

Förderung

  • Pfizer

Zitieren

APA

Piscitelli, J., Reddy, M. B., Wollenberg, L., Del Frari, L., Gong, J., Wood, L., Zhang, Y., Matschke, K., & Williams, J. H. (2024). Clinical Evaluation of the Effect of Encorafenib on Bupropion, Rosuvastatin, and Coproporphyrin I and Considerations for Statin Coadministration. Clinical Pharmacokinetics, 63(4), 483-496. https://doi.org/10.1007/s40262-024-01352-9

Vancouver

Piscitelli J, Reddy MB, Wollenberg L, Del Frari L, Gong J, Wood L, et al. Clinical Evaluation of the Effect of Encorafenib on Bupropion, Rosuvastatin, and Coproporphyrin I and Considerations for Statin Coadministration. Clinical Pharmacokinetics. 2024;63(4):483-496. doi:10.1007/s40262-024-01352-9

BibTeX
@article{Piscitelli2024,
  author = {Piscitelli, Joseph and Reddy, Micaela B and Wollenberg, Lance and Del Frari, Laurence and Gong, Jason and Wood, Linda and Zhang, Yizhong and Matschke, Kyle and Williams, Jason H},
  title = {Clinical Evaluation of the Effect of Encorafenib on Bupropion, Rosuvastatin, and Coproporphyrin I and Considerations for Statin Coadministration},
  journal = {Clinical Pharmacokinetics},
  year = {2024},
  volume = {63},
  number = {4},
  pages = {483--496},
  doi = {10.1007/s40262-024-01352-9}
}
Kostenlos starten →